Search

Your search keyword '"Motoya, Satoshi"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Motoya, Satoshi" Remove constraint Author: "Motoya, Satoshi" Database Springer Nature Journals Remove constraint Database: Springer Nature Journals
27 results on '"Motoya, Satoshi"'

Search Results

1. Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study

2. Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study

4. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey

5. Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)

6. Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)

7. A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan

8. Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial

10. Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)

11. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study

12. Postoperative therapy with infliximab for Crohn’s disease: a 2-year prospective randomized multicenter study in Japan

13. Evidence-based clinical practice guidelines for inflammatory bowel disease

18. Disease susceptibility genes shared by primary biliary cirrhosis and Crohn’s disease in the Japanese population

21. C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease

Catalog

Books, media, physical & digital resources